Jiangxi University of Traditional Chinese Medicine, Graduate School, Nanchang, Jiangxi, China.
Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Department of Respiratory and Critical Care Medicine, Nanchang, Jiangxi, China.
Front Endocrinol (Lausanne). 2024 Feb 22;15:1272314. doi: 10.3389/fendo.2024.1272314. eCollection 2024.
Low levels of high-density lipoprotein cholesterol (HDL-C) are commonly seen in patients with type 2 diabetes mellitus (T2DM). However, it is unclear whether there is an independent or causal link between HDL-C levels and T2DM. This study aims to address this gap by using the The National Health and Nutrition Examination Survey (NHANES) database and Mendelian randomization (MR) analysis.
Data from the NHANES survey (2007-2018) with 9,420 participants were analyzed using specialized software. Logistic regression models and restricted cubic splines (RCS) were used to assess the relationship between HDL-C and T2DM incidence, while considering covariates. Genetic variants associated with HDL-C and T2DM were obtained from genome-wide association studies (GWAS), and Mendelian randomization (MR) was used to evaluate the causal relationship between HDL-C and T2DM. Various tests were conducted to assess pleiotropy and outliers.
In the NHANES study, all groups, except the lowest quartile (Q1: 0.28-1.09 mmol/L], showed a significant association between HDL-C levels and reduced T2DM risk (all P < 0.001). After adjusting for covariates, the Q2 [odds ratio (OR) = 0.67, 95% confidence interval (CI): (0.57, 0.79)], Q3 [OR = 0.51, 95% CI: (0.40, 0.65)], and Q4 [OR = 0.29, 95% CI: (0.23, 0.36)] groups exhibited average reductions in T2DM risk of 23%, 49%, and 71%, respectively. In the sensitivity analysis incorporating other lipid levels, the Q4 group still demonstrates a 57% reduction in the risk of T2DM. The impact of HDL-C levels on T2DM varied with age (P for interaction = 0.006). RCS analysis showed a nonlinear decreasing trend in T2DM risk with increasing HDL-C levels (P = 0.003). In the MR analysis, HDL-C levels were also associated with reduced T2DM risk (OR = 0.69, 95% CI = 0.52-0.82; P = 1.41 × 10), and there was no evidence of pleiotropy or outliers.
This study provides evidence supporting a causal relationship between higher HDL-C levels and reduced T2DM risk. Further research is needed to explore interventions targeting HDL-C levels for reducing T2DM risk.
2 型糖尿病(T2DM)患者常出现高密度脂蛋白胆固醇(HDL-C)水平降低。然而,HDL-C 水平与 T2DM 之间是否存在独立或因果关系尚不清楚。本研究旨在利用国家健康和营养调查(NHANES)数据库和孟德尔随机化(MR)分析来解决这一空白。
使用专门的软件分析了来自 NHANES 调查(2007-2018 年)的 9420 名参与者的数据。使用逻辑回归模型和限制立方样条(RCS)来评估 HDL-C 与 T2DM 发生率之间的关系,同时考虑协变量。与 HDL-C 和 T2DM 相关的遗传变异来自全基因组关联研究(GWAS),并使用孟德尔随机化(MR)来评估 HDL-C 与 T2DM 之间的因果关系。进行了各种检验以评估偏倚和异常值。
在 NHANES 研究中,除最低四分位数(Q1:0.28-1.09mmol/L)外,所有组均显示 HDL-C 水平与降低 T2DM 风险之间存在显著关联(均 P<0.001)。在调整协变量后,Q2[比值比(OR)=0.67,95%置信区间(CI):(0.57,0.79)]、Q3[OR=0.51,95%CI:(0.40,0.65)]和 Q4[OR=0.29,95%CI:(0.23,0.36)]组的 T2DM 风险平均降低了 23%、49%和 71%。在纳入其他血脂水平的敏感性分析中,Q4 组仍显示 T2DM 风险降低 57%。HDL-C 水平对 T2DM 的影响随年龄而变化(P 交互=0.006)。RCS 分析显示,随着 HDL-C 水平的升高,T2DM 风险呈非线性下降趋势(P=0.003)。在 MR 分析中,HDL-C 水平也与降低 T2DM 风险相关(OR=0.69,95%CI=0.52-0.82;P=1.41×10),并且没有证据表明存在偏倚或异常值。
本研究提供了支持 HDL-C 水平与降低 T2DM 风险之间存在因果关系的证据。需要进一步研究探索针对 HDL-C 水平的干预措施,以降低 T2DM 风险。